Management of STEMI during the COVID-19 pandemic: Lessons learned in 2020 to prepare for 2021
Vardhmaan Jain1, Kartik Gupta2, Kirtipal Bhatia3
1Department of Cardiovascular Medicine, Heart and Vascular Institute, Cleveland Clinic, Cleveland OH, United States.
Abstract:
As the prevalence of asymptomatic COVID-19 continues to increase, there is an increasing possibility that patients with COVID-19 may presen with ST-segment elevation myocardial infarction (STEMI). With social distancing and restricted access to preventive healthcare and emergency services, the management of acute cardiac emergencies such as myocardial infarction has suffered collateral damage. Thus far, global trends suggest a decrease in STEMI activations with possible worse outcomes due to delayed presentation and management. In this review, we discuss the challenges to STEMI management in the COVID-19 era and provide potential solutions for adherence to evidence-based therapies as the pandemic progresses into the year 2021.
More Related Videos
09:52Setting Up a Stroke Team Algorithm and Conducting Simulation-based Training in the Emergency Department - A Practical Guide
Published on: January 15, 2017
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Myocarditis III: Medical Management
Angina V: Nursing Management
Coronary Artery Disease IV: Preventive Measures
